Drawing for BIOFIND

USPTO serial 76029908

BIOFIND

Reviewed by CopyMark Law Group

Reg. 2670887Status 710
Filing date
Status date
Registration date
Jan 7, 2003
Examiner
MATTHEWS, AMOS
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOFIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHARLES E. BAXLEY,

CHARLES E. BAXLEY, Hart, Baxley, Daniels & Holton90 John StreetSuite 309New York, NY 10038

Goods and services

ClassDescriptionStatusFirst use
042ONLINE INFORMATION SERVICES, NAMELY, PROVIDING A WEBSITE WITH LINKS TO OTHER CONTENT PROVIDERS IN THE FIELDS OF BIOTECHNOLOGY AND BIOPHARMACEUTICALS AND A DATABASE TO PROVIDE INFORMATION CONCERNING, PHARMACEUTICALS, BIOTECHNOLOGY, BIOINFORMATICS, BIOPHARMACEUTICALS AND RELATED COMMERCIAL HEALTHCARE ISSUES, EMPLOYMENT OPPORTUNITIES IN THE BIOTECHNOLOGY INDUSTRY, BIOTECHNOLOGY EXHIBITIONS AND EVENTS, OBTAINING FUNDING FOR INNOVATIVE BIOTECHNOLOGY RESEARCH PROJECTS, BIOTECHNOLOGY COMPANY PRESS RELEASES, BUSINESS POSTINGS AND GENERAL NEWS IN THE FIELDS OF HEALTHCARE, BIOTECHNOLOGY AND PHARMACEUTICALS INDUSTRIESSECTION 8 - CANCELLEDSep 7, 1996

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2009C8..CANCELLED SEC. 8 (6-YR)
May 13, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 31, 2007CFITCASE FILE IN TICRS
Jan 7, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2002NPUBNOTICE OF PUBLICATION
May 17, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2002DOCKASSIGNED TO EXAMINER
Jan 31, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2001IUAAUSE AMENDMENT ACCEPTED
Jun 25, 2001AUPCAMENDMENT TO USE PROCESSING COMPLETE
Mar 26, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2001IUAFUSE AMENDMENT FILED
Sep 29, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance